Abbott ABT Medical Devices — Goodwill, non-deductible
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
The total amount of goodwill reported was $35.2 billion at June 30, 2026, and $24.0 billion at December 31, 2025. Goodwill increased by $11.4 billion in the first six months of 2026 due to the completion of the Exact Sciences acquisition. Foreign currency translation adjustments decreased goodwill by $0.2 billion in the first six months of 2026. The amount of goodwill related to reportable segments at June 30, 2026, was $2.7 billion for the Established Pharmaceutical Products segment, $0.3 billion for the Nutritional Products segment, $15.0 billion for the Diagnostic Products segment, and $17.3 billion for the Medical Devices segment. The Diagnostic Products segment includes the amount of goodwill related to the Exact Sciences acquisition. There were no reductions of goodwill relating to impairments in the first six months of 2026.
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's medical devices — goodwill, non-deductible?
- Abbott (ABT) reported medical devices — goodwill, non-deductible of $17.3B in Q2 2026.
- How has Abbott's medical devices — goodwill, non-deductible changed year-over-year?
- Abbott's medical devices — goodwill, non-deductible decreased by 0.0% year-over-year, from $17.3B to $17.3B.
- What is the long-term trend for Abbott's medical devices — goodwill, non-deductible?
- Over 4 years (2021 to 2025), Abbott's medical devices — goodwill, non-deductible has grown at a 1.3% compound annual growth rate (CAGR), from $65.5B to $69B.
- What does medical devices — goodwill, non-deductible mean?
- This metric represents the portion of goodwill associated with the medical devices business segment that is not tax-deductible. It arises primarily from historical acquisitions within the cardiovascular, neuromodulation, and diabetes care product lines where the purchase price exceeded the fair value of identifiable net assets. This figure is critical for assessing the long-term carrying value of intangible assets and potential future impairment risks within the segment.
Ask your AI about Abbott's medical devices — goodwill, non-deductible.
Connect your AI assistant and compare segments, right in your chat.
